Journals / Anadolu Kardiyoloji Dergisi / 2012 / Cilt: 12 - Sayı: 2

Analysis of pharmaco-economic assessments on anti- hypertension and anti-lipidemia medicines for Turkey

Türkiye için anti-hipertansiyon ve anti-lipidemi ilaçları ile ilgili farmako- ekonomik değerlendirmelerin analizi

Pages
188–188
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KOÇKAYA, G. (2022). Analysis of pharmaco-economic assessments on anti- hypertension and anti-lipidemia medicines for Turkey. Anadolu Kardiyoloji Dergisi, Cilt: 12 - Sayı: 2, 188–188. https://ajindex.com/articles/436448

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Turkish Society of Cardiology [National Cardiology Health Politics]. Turkish Society of Cardiology; Antalya: 2007. Availaible at: URL: http://www.tkd.org.tr/ tkdout.asp?out=K0DLRPQK0NZT 2. Altun B, Arıcı M, Nergizoğlu G, Derici U, Karatan O, Turgan C, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003 J Hypertens 2005; 23: 1817-23. [CrossRef] 3. Koçkaya G, Wertheimer A. Comparison of angiotensin receptor blockers in hypertension treatment depending on year 2010 data drom reimbursement foundation view. MN Kardiyoloji 2010; 17: 222-9. 4. Koçkaya G, Wertheimer A, Koçkaya Daylan P Esen A. Considering the cost- effectiveness of statins in family practice in Turkey from a payer perspective Health 2009; 1: 274-80. [CrossRef]